poisar

Stocks · News reference

Swarmer Posts Downbeat Q2 Results, Joins TSS, ARS Pharmaceuticals, Globant And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

BenzingaAvi Kapoor

U.S. stock futures mixed, Dow down 0.1%. Swarmer Inc (NASDAQ: SWMR) shares drop 7% after reporting worse-than-expected financial results.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchNa

    Onto Innovation's Q3 Revenue Outlook: Can Sales Hit $400M?

    Onto Innovation raised its Q3 2026 revenue guidance to $380M-$400M and increased full-year advanced packaging growth outlook to 80% from 50%, driven by strong demand for Dragonfly inspection products and advanced nodes. The company's record backlog exceeded $1.1B with 60-70% relating to 2026, supporting second-half revenue growth of at least 25% and operating margins reaching 32-33%.